Tenax Therapeutics (TENX) Invested Capital (2011 - 2024)

Tenax Therapeutics has disclosed Invested Capital across 9 years of filings, most recently posting $92.0 million for Q4 2024.

• In Q4 2024, Invested Capital rose 969.81% year-over-year to $92.0 million; the TTM figure through Dec 2024 stood at $92.0 million (up 969.81% YoY), while the FY2024 annual figure was $92.0 million, up 969.81% from the prior year.
• Invested Capital came in at $92.0 million for Q4 2024 at Tenax Therapeutics, down from $97.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $97.2 million in Q3 2024 to a low of $1.5 million in Q2 2021.
• Average Invested Capital over 5 years is $16.9 million, with a median of $7.4 million recorded in 2020.
• Year-over-year, Invested Capital tumbled 55.06% in 2021 and surged 969.81% in 2024.
• Over 5 years, Invested Capital stood at $4.9 million in 2020, then fell by 12.84% to $4.2 million in 2021, then sank by 35.41% to $2.7 million in 2022, then surged by 213.65% to $8.6 million in 2023, then surged by 969.81% to $92.0 million in 2024.
• Per Business Quant data, the three most recent Invested Capital figures were $92.0 million in Q4 2024, $97.2 million in Q3 2024, and $9.2 million in Q2 2024.